These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

948 related items for PubMed ID: 21504223

  • 1. A comprehensive support vector machine binary hERG classification model based on extensive but biased end point hERG data sets.
    Shen MY, Su BH, Esposito EX, Hopfinger AJ, Tseng YJ.
    Chem Res Toxicol; 2011 Jun 20; 24(6):934-49. PubMed ID: 21504223
    [Abstract] [Full Text] [Related]

  • 2. In silico binary classification QSAR models based on 4D-fingerprints and MOE descriptors for prediction of hERG blockage.
    Su BH, Shen MY, Esposito EX, Hopfinger AJ, Tseng YJ.
    J Chem Inf Model; 2010 Jul 26; 50(7):1304-18. PubMed ID: 20565102
    [Abstract] [Full Text] [Related]

  • 3. hERG classification model based on a combination of support vector machine method and GRIND descriptors.
    Li Q, Jørgensen FS, Oprea T, Brunak S, Taboureau O.
    Mol Pharm; 2008 Jul 26; 5(1):117-27. PubMed ID: 18197627
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Prospective validation of a comprehensive in silico hERG model and its applications to commercial compound and drug databases.
    Doddareddy MR, Klaasse EC, Shagufta, Ijzerman AP, Bender A.
    ChemMedChem; 2010 May 03; 5(5):716-29. PubMed ID: 20349498
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A novel approach using pharmacophore ensemble/support vector machine (PhE/SVM) for prediction of hERG liability.
    Leong MK.
    Chem Res Toxicol; 2007 Feb 03; 20(2):217-26. PubMed ID: 17261034
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
    Wiśniowska B, Mendyk A, Fijorek K, Glinka A, Polak S.
    J Appl Toxicol; 2012 Oct 03; 32(10):858-66. PubMed ID: 22761000
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Prediction of hERG potassium channel affinity by the CODESSA approach.
    Coi A, Massarelli I, Murgia L, Saraceno M, Calderone V, Bianucci AM.
    Bioorg Med Chem; 2006 May 01; 14(9):3153-9. PubMed ID: 16426850
    [Abstract] [Full Text] [Related]

  • 19. Indexing molecules for their hERG liability.
    Rayan A, Falah M, Raiyn J, Da'adoosh B, Kadan S, Zaid H, Goldblum A.
    Eur J Med Chem; 2013 Jul 01; 65():304-14. PubMed ID: 23727540
    [Abstract] [Full Text] [Related]

  • 20. A novel structure-based virtual screening model for the hERG channel blockers.
    Du L, Li M, You Q, Xia L.
    Biochem Biophys Res Commun; 2007 Apr 20; 355(4):889-94. PubMed ID: 17331468
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 48.